Innoviva Inc INVA

NAS: INVA | ISIN: US45781M1018 30/04/2025

18,69 USD (+0,92%)

(+0,92%) 30/04/2025

Grafiek Innoviva Inc

Grafiek Innoviva Inc

1 dag1d 0,92%
1 week1w 1,69%
1 maand1m 4,18%
3 maanden3m 1,52%
6 maanden6m -2,96%
1 jaar1j 22,72%
5 jaar5j 38,96%

Innoviva Inc in het nieuws

Toon enkel gratis nieuws

12 maart 2025 · Armata Pharmaceuticals Announces $10 Million Secured Credit Agreement with Innoviva · Persbericht

4 maart 2024 · Armata Pharmaceuticals Announces $35 Million Secured Credit Agreement with Innoviva · Persbericht

11 juli 2023 · Armata Pharmaceuticals Announces New Financing and Leadership Transition to Accelerate Novel Bacteriophage Therapeutics · Persbericht

10 januari 2023 · Armata Pharmaceuticals Announces Closing of $30 Million Secured Convertible Credit Agreement with Innoviva Strategic Opportunities LLC · Persbericht

31 maart 2022 · Armata Pharmaceuticals Announces Closing of Second and Final Tranche of $45 Million Private Placement with Innoviva · Persbericht

9 februari 2022 · Armata Pharmaceuticals Announces $45 Million Investment to Support Advancement of the Company's Bacteriophage Development · Persbericht

17 maart 2021 · Armata Pharmaceuticals Announces Closing of Second and Final Tranche of $20 Million Private Placement with Innoviva · Persbericht

27 januari 2021 · Armata Pharmaceuticals Announces $20 Million Investment to Support Advancement of the Company's Bacteriophage Development Programs · Persbericht

Profiel Innoviva Inc

Fabricage van farmaceutische preparaten

Farmaceutische producten: Andere

Gezondheidstechnologie

Website: www.inva.com

Hoofdzetel: Brisbane, California Verenigde Staten

CEO: Geoffrey Hulme

Werknemers: 13

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe